Article
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies
6 May 2023
Abstract excerpt
Chimeric antigen receptor (CAR) T-cell therapy has made remarkable progress in cancer immunotherapy, but several challenges with unclear mechanisms hinder its wide clinical application. Single-cell sequencing technologies, with the powerful unbiased analysis of cellular heterogeneity and molecular patterns at unprecedented resolution, have greatly advanced our understanding of immunology and oncology. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
